THERALINK TECHNOLOGIES, INC. — Form D

THERALINK TECHNOLOGIES, INC. of GOLDEN, CO, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-29. The offering totals $185K, of which $185K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
JONATHAN F HEAD, PH.DDirectorBATON ROUGE, LA
ROBERT N HOLCOMBDirectorBATON ROUGE, LA
DANIEL S HOVERMANDirectorBATON ROUGE, LA
CHARLES L RICE, JRDirectorBATON ROUGE, LA
Brian A Barnett, M.D.Executive OfficerBATON ROUGE, LA
ANDREW A KUCHARCHUKExecutive OfficerBATON ROUGE, LA
Danica HolleyDirectorBethesda, MD
Jeffrey BuschDirectorBethesda, MD
Andrew W KucharchukDirectorGolden, CO
Matthew W Schwartz, MDDirectorGolden, CO
Mick RuxinDirectorGolden, CO
Mick RuxinExecutive OfficerGolden, CO
Yvonne ForsDirectorGolden, CO
Thomas W ChilcottExecutive OfficerGolden, CO
Andrew KucharchukDirectorGolden, CO
Thomas Chilcott, IIIExecutive OfficerGolden, CO
Mick Ruxin, MDDirectorGolden, CO
Mick Ruxin, MDExecutive OfficerGolden, CO
ROBERT L ELLIOTTDirectorBATON ROUGE, LA
ANDREW A KUCHARCHUKDirectorBATON ROUGE, LA
Jonathan F HeadDirectorBaton Rouge, LA
Jonathan F HeadExecutive OfficerBaton Rouge, LA
Charles L Rice, Jr.DirectorBaton Rouge, LA
Andrew F KucharchukExecutive OfficerBaton Rouge, LA
Charles L RiceDirectorBaton Rouge, LA

Other filings by this issuer (7)

FiledFormOfferingSold
2022-12-14D$3.4M—
2021-02-12D$4.0M$400K
2018-10-09D$1.2M$1.2M
2015-12-30D$11.1M$95K
2015-10-13D$750K$516K
2010-07-09D$175K$175K
2010-06-15D$10K$10K

More